<VariationArchive VariationID="1456429" VariationName="NC_000002.11:g.(?_145274825)_(145274988_?)del" VariationType="Deletion" Accession="VCV001456429" Version="5" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-17" DateCreated="2022-03-28" MostRecentSubmission="2024-06-09">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1458368" VariationID="1456429">
      <GeneList>
        <Gene Symbol="ZEB2" FullName="zinc finger E-box binding homeobox 2" GeneID="9839" HGNC_ID="HGNC:14881" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>2q22.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="144384081" stop="144520119" display_start="144384081" display_stop="144520119" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="145141941" stop="145277957" display_start="145141941" display_stop="145277957" Strand="-" />
          </Location>
          <OMIM>605802</OMIM>
          <Haploinsufficiency last_evaluated="2020-06-24" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=ZEB2">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-06-24" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=ZEB2">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NC_000002.11:g.(?_145274825)_(145274988_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>2q22.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" innerStart="145274825" innerStop="145274988" display_start="145274825" display_stop="145274988" variantLength="164" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.(?_145274825)_(145274988_?)del" Assembly="GRCh37">
            <Expression>NC_000002.11:g.(?_145274825)_(145274988_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000002.11:g.(?_145274825)_(145274988_?)del AND Mowat-Wilson syndrome" Accession="RCV001951144" Version="5">
        <ClassifiedConditionList TraitSetID="1308">
          <ClassifiedCondition DB="MedGen" ID="C1856113">Mowat-Wilson syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-01-20" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-01-20" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-03-28" MostRecentSubmission="2024-06-09">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">16053902</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1308" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2968" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Mowat-Wilson syndrome</ElementValue>
                <XRef ID="Mowat-Wilson+syndrome/4895" DB="Genetic Alliance" />
                <XRef ID="MONDO:0009341" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mental retardation, microcephaly, and distinct facial features with or without Hirschsprung disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hirschsprung disease mental retardation syndrome</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MOWS</ElementValue>
                <XRef Type="MIM" ID="235730" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">ZEB2</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9673" />
                <XRef ID="9673" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Mowat-Wilson syndrome (MWS) is characterized by distinctive facial features (widely spaced eyes, broad eyebrows with a medial flare, low-hanging columella, prominent or pointed chin, open-mouth expression, and uplifted earlobes with a central depression), congenital heart defects with predilection for abnormalities of the pulmonary arteries and/or valves, Hirschsprung disease or chronic constipation, genitourinary anomalies (particularly hypospadias in males), and hypogenesis or agenesis of the corpus callosum. Most affected individuals have moderate-to-severe intellectual disability. Speech is typically limited to a few words or is absent, with relative preservation of receptive language skills. Growth restriction with microcephaly and seizure disorder are also common. Most affected people have a happy demeanor and a wide-based gait that can sometimes be confused with Angelman syndrome.</Attribute>
                <XRef ID="NBK1412" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301585</ID>
                <ID Source="BookShelf">NBK1412</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2011">
                <ID Source="PubMed">21343952</ID>
              </Citation>
              <XRef ID="2152" DB="Orphanet" />
              <XRef ID="C1856113" DB="MedGen" />
              <XRef ID="MONDO:0009341" DB="MONDO" />
              <XRef Type="MIM" ID="235730" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4262957" SubmissionDate="2024-06-04" DateLastUpdated="2024-06-09" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="NM_014795.3_2_Deletion (exon 2)|MedGen:C1856113" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002239029" DateUpdated="2024-06-09" DateCreated="2022-03-28" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-01-20">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16053902</ID>
          </Citation>
          <Comment>This variant has not been reported in the literature in individuals affected with ZEB2-related conditions. This variant is a gross deletion of the genomic region encompassing exon(s) 2 of the ZEB2 gene, which includes the initiator codon. This deletion extends beyond the assayed region for this gene and therefore may encompass additional genes. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ZEB2 are known to be pathogenic (PMID: 16053902). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ZEB2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000002.11:g.(?_145274825)_(145274988_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1856113" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12699154</SubmissionName>
          <SubmissionName>SUB14505679</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4262957" TraitType="Disease" MappingType="XRef" MappingValue="C1856113" MappingRef="MedGen">
        <MedGen CUI="C1856113" Name="Mowat-Wilson syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

